Listed
Stock Code: 290650
| Company Name | (주)엘앤씨바이오 |
| English Name | L&C BIO Co., Ltd |
| Business Reg. No. | 1298664008 |
| CEO | 이환철, 이재호 (각자 대표이사) |
| Address | 경기도 성남시 중원구 둔촌대로 474, 605호, 606호, 607호 (선텍시티) |
| Industry | 그 외 기타 의료용품 및 의약 관련제품 제조업 |
| Industry Code | 212 |
| Established | 2011-08-02 |
| Phone | 031-776-2975 |
| Website | www.lncbio.co.kr |
| Regular Employees | 11persons |
| Corp. Reg. No. | 1311110288992 |
Venture Certified
| 기술평가보증기업(기금) | 2012-05-17 ~ 2014-05-16 | 20120104533 | 2012-05-17 |
| 기술평가보증기업(기금) | 2014-05-17 ~ 2016-05-16 | 20140107445 | 2012-05-17 |
| 기술평가보증기업(기금) | 2016-05-17 ~ 2018-05-16 | 20160107385 | 2012-05-17 |
| 기술평가보증기업(기금) | 2018-05-17 ~ 2020-05-16 | 20180106284 | 2012-05-17 |
| 기술평가보증기업(기금) | 2020-05-17 ~ 2022-05-16 | 20200105329 | 2012-05-17 |
| 혁신성장유형 | 2022-05-17 ~ 2025-05-16 | 20220504030036 | 2012-05-17 |
| 혁신성장유형 | 2025-05-17 ~ 2028-05-16 | 20250520030049 | 2012-05-17 |
Revenue CAGR +16.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 562B | 561B | 417B |
| Operating Profit | 17B | 80B | 67B |
| Net Profit | -115B | 631B | 41B |
| Total Assets | 2,832B | 2,238B | 1,592B |
| Total Liabilities | 1,573B | 886B | 713B |
| Total Equity | 1,258B | 1,352B | 879B |
Debt Ratio Surge (+60pp YoY)
▲ 14.8%
▼ 77.0%
▼ 80.2%
▲ 70.6%
▼ 135.7%
| Name | Position | Role |
|---|---|---|
| 이환철, 이재호 (각자 대표이사) | 대표이사 | 대표 |
| NPS Subscribers | 11persons |
| CEO | 이환철, 이재호 (각자 대표이사) |
| Est. Avg. Annual Salary | 4,66210K (38810K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2007-02-01 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 인체 유래 조직을 포함하는 규칙성 치밀결합조직 치료용 조성물 | 주식회사 엘앤씨바이오 | 1020250060504 | 2025-05-09 | 공개 |
| 무세포 동종진피를 포함하는 치주조직 재생유도재 및 그 제조 방법 | 주식회사 엘앤씨바이오 | 1020240198772 | 2024-12-27 | 등록 |
| 3D 프린팅 기술을 이용한 골 스캐폴드 및 그 제조방법 | 주식회사 엘앤씨바이오 | 1020230150330 | 2023-11-02 | 등록 |
| 인체 이식을 위한 3D 프린팅 구조체 및 그 제조방법 | 주식회사 엘앤씨바이오 | 1020210167968 | 2021-11-30 | 거절 |
| 동물 피부 유래의 초미세 무세포 진피 제조 방법 | 주식회사 엘앤씨바이오 | 1020210153863 | 2021-11-10 | 등록 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
2 Additional Data Sources
{
"address": "경기도 성남시",
"ceo_name": "이환철",
"certificate": [
{
"cert_number": "20120104533",
"changes": "",
"disclosure_date": "2012-05-17",
"first_cert_date": "2012-05-17",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-05-17 ~ 2014-05-16"
},
{
"cert_number": "20140107445",
"changes": "",
"disclosure_date": "2014-06-23",
"first_cert_date": "2012-05-17",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-05-17 ~ 2016-05-16"
},
{
"cert_number": "20160107385",
"changes": "",
"disclosure_date": "2016-06-17",
"first_cert_date": "2012-05-17",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-05-17 ~ 2018-05-16"
},
{
"cert_number": "20180106284",
"changes": "",
"disclosure_date": "2018-05-25",
"first_cert_date": "2012-05-17",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-05-17 ~ 2020-05-16"
},
{
"cert_number": "20200105329",
"changes": "",
"disclosure_date": "2020-04-27",
"first_cert_date": "2012-05-17",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-05-17 ~ 2022-05-16"
},
{
"cert_number": "20220504030036",
"changes": "",
"disclosure_date": "2022-05-04",
"first_cert_date": "2012-05-17",
"no": "6",
"type": "혁신성장유형",
"valid_period": "2022-05-17 ~ 2025-05-16"
},
{
"cert_number": "20250520030049",
"changes": "",
"disclosure_date": "2025-05-20",
"first_cert_date": "2012-05-17",
"no": "7",
"type": "혁신성장유형",
"valid_period": "2025-05-17 ~ 2028-05-16"
}
],
"company_name": "주식회사 엘앤씨바이오",
"financials": {
"2022": {
"capital_stock": 11388444000,
"cost_of_sales": 18989131000,
"current_assets": 57879101000,
"current_liabilities": 16021705000,
"gross_profit": 22753795000,
"net_income": 4093377000,
"net_income_bs": 4135811000,
"non_current_assets": 101291996000,
"non_current_liabilities": 55252267000,
"non_operating_expenses": 4805368000,
"non_operating_income": 2197320000,
"operating_profit": 6701425000,
"revenue": 41742926000,
"sga_expenses": 16052370000,
"total_assets": 159171097000,
"total_equity": 87897125000,
"total_liabilities": 71273972000
},
"2023": {
"capital_stock": 11388444000,
"cost_of_sales": 25449753000,
"current_assets": 124464758000,
"current_liabilities": 85639318000,
"gross_profit": 30681800000,
"net_income": 63051145000,
"net_income_bs": 48880853000,
"non_current_assets": 99286419000,
"non_current_liabilities": 2923507000,
"non_operating_expenses": 10371109000,
"non_operating_income": 65467133000,
"operating_profit": 7955121000,
"revenue": 56131553000,
"sga_expenses": 22726678000,
"total_assets": 223751178000,
"total_equity": 135188353000,
"total_liabilities": 88562825000
},
"2024": {
"capital_stock": 11388444000,
"cost_of_sales": 27858534000,
"current_assets": 121716660000,
"current_liabilities": 140418055000,
"gross_profit": 28310330000,
"net_income": -11511352000,
"net_income_bs": -7078467000,
"non_current_assets": 161445173000,
"non_current_liabilities": 16918668000,
"non_operating_expenses": 18630080000,
"non_operating_income": 5436486000,
"operating_profit": 1682242000,
"revenue": 56168864000,
"sga_expenses": 26628088000,
"total_assets": 283161833000,
"total_equity": 125825110000,
"total_liabilities": 157336723000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [],
"phone": "02-541-****",
"source": "pg_migration"
}{
"address": "서울특별시 서초구 강남대로",
"brno": "214880****",
"cappedWarning": false,
"companyName": "(주)엘앤씨바이오",
"estimatedAvgAnnualSalary": 46619940,
"estimatedAvgMonthlySalary": 3884995,
"fetchedAt": "2026-03-05T18:16:57.858Z",
"industryCode": "515080",
"industryName": "의료 기기 도매업",
"joinDate": "20070201",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 4059820,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6369263",
"status": "1",
"styleCode": "1",
"subscriberCount": 11,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| SME Status Info | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |